Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio

Abstract

This study aimed to evaluate whether the interleukin-6 (IL-6) and interleukin-10 (IL-10) ratio (IL-6/IL-10) can be used as a prognostic marker of recurrence following bacillus Calmette-Guérin (BCG) therapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC). One hundred and twenty-one consecutive urological patients (72 affected by high… (More)

Topics

5 Figures and Tables

Cite this paper

@inproceedings{Cai2012PredictionOR, title={Prediction of response to bacillus Calmette-Gu{\'e}rin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio}, author={Tommaso Cai and Gabriella Nesi and S. Mazzoli and Francesca Meacci and Galliano Tinacci and Lorenzo Giuseppe Luciani and Vincenzo Ficarra and Gianni Malossini and Riccardo Bartoletti}, booktitle={Experimental and therapeutic medicine}, year={2012} }